Corrigendum to "Oral treatment with enrofloxacin early in life promotes Th2-mediated immune response in mice" [Pharmacol. Rep. 68 (2016) 44-50].

: The authors wish to note an incorrectly listed financial support grants. The National Science Centre grants 2011/01/B/NZ6/00300 and 2012/05/B/NZ6/00997 were inadvertently listed. The authors regret this error. The correct Acknowledgements read as follows.